First-Of-Kind Treatments Win Funding in England & Wales
NICE Fast-Tracks Novartis’s Beovu
Executive Summary
Treatments for non-small cell lung cancer, Pompe disease and two main forms of ANCA-associated vasculitis from Roche, Sanofi and CSL Vifor respectively are to be made available for patients on the National Health Service.